Evidence map›Paper›PMID 41255310›Full record

ArticleeLife2025

MCAK recognizes the nucleotide-dependent feature at growing microtubule ends.

Wei Chen, Yin-Long Song, Jian-Feng He, Xin Liang

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Structural switching of tubulin in the microtubule lattice.Biochemical Society transactions · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wei ChenIDG/McGovern Institute for Brain Research, State Key Laboratory of Complex, Severe, and Rare Diseases, School of Life Sciences, Tsinghua University, Beijing, China.ORCID 0000-0001-7454-3882
Yin-Long SongIDG/McGovern Institute for Brain Research, State Key Laboratory of Complex, Severe, and Rare Diseases, School of Life Sciences, Tsinghua University, Beijing, China.ORCID 0000-0002-1666-9628
Jian-Feng HeIDG/McGovern Institute for Brain Research, State Key Laboratory of Complex, Severe, and Rare Diseases, School of Life Sciences, Tsinghua University, Beijing, China.ORCID 0000-0001-6995-2980
Xin LiangIDG/McGovern Institute for Brain Research, State Key Laboratory of Complex, Severe, and Rare Diseases, School of Life Sciences, Tsinghua University, Beijing, China.ORCID 0000-0001-7915-8094

Funding

National Natural Science Foundation of China 32070704National Natural Science Foundation of China 32370730
6 · The paper itself

Abstract

The growing plus-end is a key regulatory site for microtubule dynamics. MCAK (mitotic centromere-associated kinesin), a microtubule depolymerizing kinesin, is an end-binding regulator of catastrophe frequency. It is intriguing how MCAK specifically binds to growing microtubule ends. Here, we measure the end-binding kinetics of MCAK using single-molecule imaging and reveal that MCAK not only binds to the distalmost ends, but also to the proximal region of GTP cap where EB1 preferentially binds. Further analysis shows that MCAK strongly binds to GTPγS microtubules which mimic the GDP·Pi-tubulin-enriched region of GTP cap, and this binding preference is dependent on the nucleotide state of MCAK. This finding suggests that MCAK recognizes the nucleotide-dependent feature of microtubule ends. Moreover, we show that although MCAK and XMAP215 partly share binding regions at the distalmost ends, they act largely independently, influencing catastrophe frequency and growth rate, respectively. Overall, our findings provide new insights into how MCAK regulates microtubule end dynamics.

Indexed as

KinesinsMicrotubulesNucleotidesGuanosine TriphosphateHumansMicrotubule-Associated ProteinsProtein BindingGuanosine TriphosphateKIF2C protein, humanKinesinsMicrotubule-Associated ProteinsNucleotidesbiochemistrychemical biologydepolymerizationend bindingGTP capMCAKmicrotubule dynamicsnone

Identifiers

PMID41255310
PMCPMC12629592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.